Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This move, approved by the independent Compensation Committee, aligns with Nasdaq Listing Rule 5635(c)(4) and aims to attract talent to support Dianthus' development of therapies for severe autoimmune diseases.
Dianthus Therapeutics' inducement grants provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 03, 2026 04:41 WIB: Of 150 priced US health-sector stocks, 49 rose and 99 fell today. Notable movers include NTRA at USD 376.38 with a 1-day change of -9.12% and a typical hold time of 19 days; ABCL at USD 11.19, down 8.80%, with Pluang order activity showing 63% Sell and 37% Buy; and HIMS at USD 25.30, down 8.60%, with 0% Sell and 100% Buy activity, and a typical hold time of 23 days.
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
Amazon.com is reinforcing its market position with AWS backlog surging to $580 billion and aiming for a $1 trillion revenue run rate. Despite concerns over aggressive AI-related capital expenditures and delayed free cash flow recovery, management jus...
Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...
Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...
